151 related articles for article (PubMed ID: 38361239)
1. Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation.
Mohamed ME; Saqr A; Staley C; Onyeaghala G; Teigen L; Dorr CR; Remmel RP; Guan W; Oetting WS; Matas AJ; Israni AK; Jacobson PA
Transplantation; 2024 Feb; ():. PubMed ID: 38361239
[TBL] [Abstract][Full Text] [Related]
2. Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell Transplantation.
Saqr A; Carlson B; Staley C; Rashidi A; Al-Kofahi M; Kaiser T; Holtan S; MacMillan M; Young JA; Jurdi NE; Weisdorf D; Khoruts A; Jacobson PA
Transplant Cell Ther; 2022 Jul; 28(7):372.e1-372.e9. PubMed ID: 35489611
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
4. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery.
Kamath S; Stringer AM; Prestidge CA; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1315-1331. PubMed ID: 37405390
[TBL] [Abstract][Full Text] [Related]
5. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.
Monchaud C; Marquet P
Clin Pharmacokinet; 2009; 48(7):419-62. PubMed ID: 19691367
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.
Kuypers DR
Drugs Aging; 2009; 26(9):715-37. PubMed ID: 19728747
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?
Lam S; Partovi N; Ting LS; Ensom MH
Ann Pharmacother; 2008 Jul; 42(7):1037-47. PubMed ID: 18594053
[TBL] [Abstract][Full Text] [Related]
9. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
10. Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome.
Gerardin Y; Timberlake S; Allegretti JR; Smith MB; Kassam Z
J Infect Dis; 2021 Jun; 223(12 Suppl 2):S276-S282. PubMed ID: 33330910
[TBL] [Abstract][Full Text] [Related]
11. Role of the gut microbiome in cardiovascular drug response: The potential for clinical application.
Steiner HE; Gee K; Giles J; Knight H; Hurwitz BL; Karnes JH
Pharmacotherapy; 2022 Feb; 42(2):165-176. PubMed ID: 34820870
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive drugs in paediatric liver transplantation.
van Mourik ID; Kelly DA
Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
del Mar Fernández De Gatta M; Santos-Buelga D; Domínguez-Gil A; García MJ
Clin Pharmacokinet; 2002; 41(2):115-35. PubMed ID: 11888332
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
Grinyó JM; Ekberg H; Mamelok RD; Oppenheimer F; Sánchez-Plumed J; Gentil MA; Hernandez D; Kuypers DR; Brunet M
Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111
[TBL] [Abstract][Full Text] [Related]
15. Microbiome therapeutics for the treatment of recurrent
Bloom PP; Young VB
Expert Opin Biol Ther; 2023 Jan; 23(1):89-101. PubMed ID: 36536532
[TBL] [Abstract][Full Text] [Related]
16. [Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice].
Naito T
Yakugaku Zasshi; 2010 Dec; 130(12):1695-700. PubMed ID: 21139397
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation for treatment of patients with recurrent
Voth E; Khanna S
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
[TBL] [Abstract][Full Text] [Related]
18. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
[TBL] [Abstract][Full Text] [Related]
19. Bringing pharmacomicrobiomics to the clinic through well-designed studies.
Steiner HE; Patterson HK; Giles JB; Karnes JH
Clin Transl Sci; 2022 Oct; 15(10):2303-2315. PubMed ID: 35899413
[TBL] [Abstract][Full Text] [Related]
20. Pharmacomicrobiomics and Drug-Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy.
Torres-Carrillo N; Martínez-López E; Torres-Carrillo NM; López-Quintero A; Moreno-Ortiz JM; González-Mercado A; Gutiérrez-Hurtado IA
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
